Taylor and Francis Group, The Journal of Maternal-Fetal and Neonatal Medicine, 3(26), p. 263-269, 2012
DOI: 10.3109/14767058.2012.733747
Full text: Unavailable
To investigate the serum level distribution of angiogenic markers (PlGF, endoglin, sFlt-1) and acute-phase proteins (SAA, CRP) in patients with HELLP syndrome or preeclampsia (PE) including matched controls.